Raffles Medical Group Ltd
SGX:BSL

Watchlist Manager
Raffles Medical Group Ltd Logo
Raffles Medical Group Ltd
SGX:BSL
Watchlist
Price: 1.02 SGD Market Closed
Market Cap: S$1.9B

Raffles Medical Group Ltd
Other Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Raffles Medical Group Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Raffles Medical Group Ltd
SGX:BSL
Other Current Liabilities
S$89m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
13%
I
ISEC Healthcare Ltd
SGX:40T
Other Current Liabilities
S$1.2m
CAGR 3-Years
-45%
CAGR 5-Years
-19%
CAGR 10-Years
9%
O
Oue Lippo Healthcare Ltd
SGX:5WA
Other Current Liabilities
S$22.7m
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
29%
A
Asia Vets Holdings Ltd
SGX:5RE
Other Current Liabilities
S$393k
CAGR 3-Years
-4%
CAGR 5-Years
-30%
CAGR 10-Years
17%
Thomson Medical Group Ltd
SGX:A50
Other Current Liabilities
S$12.4m
CAGR 3-Years
-12%
CAGR 5-Years
5%
CAGR 10-Years
-13%
No Stocks Found

Raffles Medical Group Ltd
Glance View

Market Cap
1.9B SGD
Industry
Health Care

In the bustling heart of Singapore, Raffles Medical Group Ltd. has established itself as a cornerstone of the healthcare sector in Asia. Founded in 1976, the company has cultivated a reputation for comprehensive medical services, seamlessly blending the professional expertise and state-of-the-art technology. From its humble origins as a two-doctor clinic, Raffles Medical has expanded into a formidable network, operating over 100 clinics and a renowned tertiary hospital in Singapore. Its operation spans across key Asian markets, including China, Vietnam, and Japan. The company’s focus on providing quality healthcare is evident in its diverse range of services, which include everything from primary care and dental clinics to more specialized services such as radiology and laboratory services. Through a blend of clinical care and innovation, Raffles Medical Group continues to meet the healthcare needs of the growing population in the region. Financially, Raffles Medical Group’s business model is multifaceted, effectively capitalizing on various revenue streams. The company derives its income from both its extensive suite of outpatient and inpatient services. Outpatient services, through its primary care clinics, offer a steady stream of revenue as these clinics handle routine check-ups, vaccinations, and chronic disease management. Inpatient services, provided mainly through Raffles Hospital in Singapore, include surgery, intensive care, and emergency care, catering to an international clientele that values the hospital’s esteemed integrated healthcare model. Additionally, the company diversifies its income with corporate health insurance services, which leverage its medical expertise to provide tailored health insurance plans, thereby enmeshing itself further into the fabric of its clientele's healthcare journey. This diversification not only strengthens the company’s financial foundation but also positions it well for growth in an industry that revolves around the constancy of human health needs.

BSL Intrinsic Value
1 SGD
Overvaluation 2%
Intrinsic Value
Price S$1.02

See Also

What is Raffles Medical Group Ltd's Other Current Liabilities?
Other Current Liabilities
89m SGD

Based on the financial report for Dec 31, 2025, Raffles Medical Group Ltd's Other Current Liabilities amounts to 89m SGD.

What is Raffles Medical Group Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
13%

Over the last year, the Other Current Liabilities growth was -16%. The average annual Other Current Liabilities growth rates for Raffles Medical Group Ltd have been 13% over the past three years , 12% over the past five years , and 13% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett